Literature DB >> 23807282

Further genetic and clinical insights of posterior polymorphous corneal dystrophy 3.

Petra Liskova1, Michalis Palos, Alison J Hardcastle, Andrea L Vincent.   

Abstract

IMPORTANCE: Posterior polymorphous corneal dystrophy (PPCD) is a very rare disorder characterized by primary changes of the posterior corneal layers. Sequence variants in 3 genes are associated with the development of PPCD, including ZEB1 that is responsible for PPCD3. Evidence suggests at least 1 more gene remains to be identified.
OBJECTIVE: To determine the molecular genetic cause of PPCD3.
DESIGN: We performed extensive ophthalmological examination, including rotating Scheimpflug imaging technology and specular microscopy, and direct sequencing of the ZEB1 coding region. Comprehensive review of published PPCD3-causing variants was undertaken.
SETTING: Ophthalmology department of a university hospital. PARTICIPANTS: Four Czech probands. MAIN OUTCOMES AND MEASURES: Results of ophthalmological examination and direct sequencing of the ZEB1 coding region.
RESULTS: The following 2 novel frameshift mutations within ZEB1 were identified: c.2617dup in exon 8 in a 22-year-old woman, considered to be most likely de novo in origin, and c.698dup in exon 6 in a 20-year-old man. The first patient had mild changes consistent with PPCD and bilateral best-corrected visual acuity of 1.00. The corneal phenotype of the patient in the second case was more severe, with best-corrected visual acuity of 0.40 OD and 0.05 OS. Corneas of both probands were abnormally steep (keratometry readings, flat ≥ 47.4 diopters [D] and steep ≥ 49.2 D) with increased pachymetry values but no pattern indicative of keratoconus. Specular microscopy in both patients revealed reduced endothelial cell density (range, 1055/mm² to 1655/mm²). Both probands had a history of surgery for inguinal hernia; the male patient also reported hydrocele. CONCLUSIONS AND RELEVANCE: Nucleotide changes within the coding region of ZEB1 underlie the pathogenesis of PPCD in 4 of 23 Czech probands (17%). The cumulative de novo ZEB1 mutation rate is at least 14%. Possible involvement of ZEB1 sequence variants not readily identified by direct sequencing of coding regions needs to be further investigated. Our findings also have implications for patient counseling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807282     DOI: 10.1001/jamaophthalmol.2013.405

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  14 in total

1.  Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum.

Authors:  Michelle S Jang; Ashley N Roldan; Ricardo F Frausto; Anthony J Aldave
Journal:  Vision Res       Date:  2014-04-26       Impact factor: 1.886

2.  Transcriptome analysis of the human corneal endothelium.

Authors:  Ricardo F Frausto; Cynthia Wang; Anthony J Aldave
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-06       Impact factor: 4.799

3.  Congenital Corneal Endothelial Dystrophies Resulting From Novel De Novo Mutations.

Authors:  Khrishen Cunnusamy; Charles B Bowman; Walter Beebe; Xin Gong; R Nick Hogan; V Vinod Mootha
Journal:  Cornea       Date:  2016-02       Impact factor: 2.651

4.  Functional impact of ZEB1 mutations associated with posterior polymorphous and Fuchs' endothelial corneal dystrophies.

Authors:  Duk-Won D Chung; Ricardo F Frausto; Lydia B Ann; Michelle S Jang; Anthony J Aldave
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-04       Impact factor: 4.799

5.  Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3.

Authors:  Petra Liskova; Cerys J Evans; Alice E Davidson; Marketa Zaliova; Lubica Dudakova; Marie Trkova; Viktor Stranecky; Nicole Carnt; Vincent Plagnol; Andrea L Vincent; Stephen J Tuft; Alison J Hardcastle
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

6.  Non-Penetrance for Ocular Phenotype in Two Individuals Carrying Heterozygous Loss-of-Function ZEB1 Alleles.

Authors:  Lubica Dudakova; Viktor Stranecky; Lenka Piherova; Tomas Palecek; Nikolas Pontikos; Stanislav Kmoch; Pavlina Skalicka; Manuela Vaneckova; Alice E Davidson; Petra Liskova
Journal:  Genes (Basel)       Date:  2021-04-30       Impact factor: 4.096

7.  CUGC for posterior polymorphous corneal dystrophy (PPCD).

Authors:  Alice E Davidson; Nathaniel J Hafford-Tear; Lubica Dudakova; Amanda N Sadan; Nikolas Pontikos; Alison J Hardcastle; Stephen J Tuft; Petra Liskova
Journal:  Eur J Hum Genet       Date:  2019-06-14       Impact factor: 5.351

Review 8.  Genetics in Keratoconus: where are we?

Authors:  Yelena Bykhovskaya; Benjamin Margines; Yaron S Rabinowitz
Journal:  Eye Vis (Lond)       Date:  2016-06-27

9.  Confirmation of the OVOL2 Promoter Mutation c.-307T>C in Posterior Polymorphous Corneal Dystrophy 1.

Authors:  Doug D Chung; Ricardo F Frausto; Aleck E Cervantes; Katherine M Gee; Marina Zakharevich; Evelyn M Hanser; Edwin M Stone; Elise Heon; Anthony J Aldave
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

10.  Association of a Chromosomal Rearrangement Event with Mouse Posterior Polymorphous Corneal Dystrophy and Alterations in Csrp2bp, Dzank1, and Ovol2 Gene Expression.

Authors:  Anna L Shen; Susan A Moran; Edward A Glover; Norman R Drinkwater; Rebecca E Swearingen; Leandro B Teixeira; Christopher A Bradfield
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.